1St Orthopaedics and Traumatology Clinic, IRCCS Istituto Ortopedico Rizzoli, via Giulio Cesare Pupilli, 1, 40136, Bologna, Italy.
Musculoskelet Surg. 2024 Jun;108(2):125-132. doi: 10.1007/s12306-023-00805-x. Epub 2024 Feb 10.
The purpose of the study was to investigate whether arthroscopic treatment of carpal scaphoid nonunions by osteosynthesis with bone grafting represents a successful surgical technique. This systematic literature review, conducted following the PRISMA guidelines, explores the past 10 years of clinical studies concerning the arthroscopic treatment of scaphoid nonunions. The most relevant keywords were used to search the databases, and the Downs and Black 27-item checklist has been used as quality assessment tool. Twelve papers that meet the premised eligibility criteria have been identified. These studies demonstrate the efficacy of this surgical solution, achieving a postoperative union rate of 96% in the average time of 13.5 weeks. Regardless of the method of synthesis and the origin of the graft used, excellent results were obtained. Patients who underwent this procedure reported a pain reduction of almost 80% compared to the preoperative level, improvement in grip strength close to 40%, and recovery in wrist function during daily activities. Arthroscopy has numerous advantages compared to the open approach. These are technically recognized by the surgeon and by the patient. Some disadvantages include a longer intraoperative time and considerable significant technical difficulty. Arthroscopic treatment of scaphoid nonunion by osteosynthesis with bone graft achieves a 96% union rate of the treated scaphoid with satisfying clinical results.
本研究旨在探讨经皮骨移植内固定治疗腕舟骨骨不连的关节镜治疗是否代表一种成功的手术技术。本系统文献回顾按照 PRISMA 指南进行,探讨了过去 10 年来关于关节镜治疗舟骨骨不连的临床研究。使用最相关的关键字搜索数据库,并使用 Downs 和 Black 27 项清单作为质量评估工具。确定了符合预设资格标准的 12 篇论文。这些研究表明该手术方法的疗效,术后平均 13.5 周的愈合率为 96%。无论采用何种固定方法和移植物来源,均获得了良好的效果。与术前相比,接受该手术的患者疼痛减轻了近 80%,握力增加了近 40%,日常活动中腕关节功能恢复。与开放式手术相比,关节镜具有许多优势。这些优势得到了外科医生和患者的认可。一些缺点包括手术时间较长和相当大的技术难度。经皮骨移植内固定治疗腕舟骨骨不连的关节镜治疗,其愈合率达到 96%,临床疗效满意。